SEC Form 4 · accession 0001209191-19-012192
PURE BIOSCIENCE, INC. · PURE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dale Okuno
Director
Period of report
Feb 19, 2019
Accepted (ET)
Feb 21, 2019 · 5:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001006028
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 19, 2019 | X | 213,333 | $0.35 | A | 4,585,284 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant | $0.75 | Feb 19, 2019 | D | 213,333 | D | Aug 22, 2014 | Aug 22, 2019 | Common Stock | 213,333 | 0 | D |
| Warrant | $0.35 | Feb 19, 2019 | A | 213,333 | A | Aug 22, 2014 | Aug 22, 2019 | Common Stock | 213,333 | 213,333 | D |
| Warrant | $0.35 | Feb 19, 2019 | X | 213,333 | D | Aug 22, 2014 | Aug 22, 2019 | Common Stock | 213,333 | 0 | D |
Explanation of responses
- F1The reported transactions relate to an amendment of the exercise price of an outstanding warrant from $0.75 per share to $0.35 per share of Common Stock, contingent upon the Reporting Person immediately exercising the Warrant. As a result of this amendment, the outstanding warrant was deemed canceled and a replacement warrant was issued for the same number of shares of Common Stock, but with the reduced exercise price. The outstanding warrant was originally issued on August 2014.